{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:35:34Z","timestamp":1791290134740,"version":"4.3.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10067-021-05602-0","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T03:03:23Z","timestamp":1615431803000},"page":"3615-3626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["High serum IgA and activated Th17 and Treg predict the efficacy of abatacept in patients with early, seropositive rheumatoid arthritis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9927-7936","authenticated-orcid":false,"given":"Jun","family":"Inamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"5602_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrd1989","volume":"5","author":"L Moreland","year":"2006","unstructured":"Moreland L, Bate G, Kirkpatrick P (2006) Abatacept. Nature Rev Drug Discov 5:185\u2013186","journal-title":"Nature Rev Drug Discov"},{"key":"5602_CR2","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1136\/annrheumdis-2018-214885","volume":"78","author":"M Takeshita","year":"2019","unstructured":"Takeshita M, Suzuki K, Kondo Y, Morita R, Okuzono Y, Koga K, Kassai Y, Gamo K, Takiguchi M, Kurisu R, Mototani H, Ebisuno Y, Yoshimura A, Takeuchi T (2019) Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell. Ann Rheum Dis 78:1346\u20131356","journal-title":"Ann Rheum Dis"},{"key":"5602_CR3","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1056\/NEJM199610313351807","volume":"335","author":"H Reiser","year":"1996","unstructured":"Reiser H, Stadecker MJ (1996) Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 335:1369\u20131377","journal-title":"N Engl J Med"},{"key":"5602_CR4","first-page":"1234","volume":"77","author":"K Oryoji","year":"2018","unstructured":"Oryoji K, Yoshida K, Kashiwado Y, Tanaka K, Mizuki SI, Tsukamoto H, Kamada K, Akashi K (2018) Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis. Ann Rheum Dis 77:1234\u20131236","journal-title":"Ann Rheum Dis"},{"key":"5602_CR5","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/art.39595","volume":"68","author":"JE Gottenberg","year":"2016","unstructured":"Gottenberg JE, Courvoisier DS, Hernandez MV, Iannone F, Lie E, Canh\u00e3o H, Pavelka K, Hetland ML, Turesson C, Mariette X, Finckh A (2016) Brief report: association of rheumatoid factor and anti-citrullinated protein antibody positivity with better effectiveness of abatacept: results from the Pan-European registry analysis. Arthritis Rheumatol 68:1346\u20131352","journal-title":"Arthritis Rheumatol"},{"key":"5602_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/annrheumdis-2015-207942","volume":"75","author":"J Sokolove","year":"2016","unstructured":"Sokolove J, Schiff M, Fleischmann R, Weinblatt ME, Connolly SE, Johnsen A, Zhu J, Maldonado MA, Patel S, Robinson WH (2016) Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial. Ann Rheum Dis 75:709\u2013714","journal-title":"Ann Rheum Dis"},{"key":"5602_CR7","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s10067-017-3588-7","volume":"36","author":"LR Harrold","year":"2017","unstructured":"Harrold LR, Litman HJ, Connolly SE, Kelly S, Hua W, Alemao E, Rosenblatt L, Rebello S, Kremer JM (2017) A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity\/remission in clinical practice? Clin Rheumatol 36:1215\u20131220","journal-title":"Clin Rheumatol"},{"key":"5602_CR8","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsk\u00fd J, Wolfe F, Hawker G (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"4","key":"5602_CR9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/annrheumdis-2012-202778","volume":"72","author":"R Knevel","year":"2013","unstructured":"Knevel R, Lukas C, van der Heijde D, Rincheval N, Combe B, van der Helm-van Mil AH (2013) Defining erosive disease typical of RA in the light of the ACR\/EULAR 2010 criteria for rheumatoid arthritis; results of the data driven phase. Ann Rheum Dis 72(4):590\u2013595","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 39","key":"5602_CR10","first-page":"S100","volume":"23","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Smolen J (2005) The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23(5 Suppl 39):S100\u2013S108","journal-title":"Clin Exp Rheumatol"},{"key":"5602_CR11","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1093\/bioinformatics\/btx378","volume":"33","author":"T Xu","year":"2017","unstructured":"Xu T, Le TD, Liu L et al (2017) CancerSubtypes: R\/Bioconductor package for molecular cancer subtype identification, validation and visualization. Bioinformatics. 33:3131\u20133133","journal-title":"Bioinformatics."},{"key":"5602_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1023949509487","volume":"52","author":"S Monti","year":"2003","unstructured":"Monti S et al (2003) Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach Learn 52:91\u2013118","journal-title":"Mach Learn"},{"key":"5602_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nmeth.2810","volume":"11","author":"B Wang","year":"2014","unstructured":"Wang B, Mezlini AM, Demir F, Fiume M, Tu Z, Brudno M, Haibe-Kains B, Goldenberg A (2014) Similarity network fusion for aggregating data types on a genomic scale. Nat Methods 11:333\u2013337","journal-title":"Nat Methods"},{"key":"5602_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","volume":"20","author":"PJ Rousseeuw","year":"1987","unstructured":"Rousseeuw PJ (1987) Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math 20:53\u201365","journal-title":"J Comput Appl Math"},{"key":"5602_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/biomet\/58.3.453","volume":"58","author":"KR Gabriel","year":"1971","unstructured":"Gabriel KR (1971) The biplot graphic display of matrices with application to principal component analysis. Biometrika 58:453\u2013467","journal-title":"Biometrika"},{"key":"5602_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/wcs.1203","volume":"4","author":"MC Hout","year":"2013","unstructured":"Hout MC, Papesh MH, Goldinger SD (2013) Multidimensional scaling. Wiley Interdiscip Rev Cogn Sci 4:93\u2013103","journal-title":"Wiley Interdiscip Rev Cogn Sci"},{"key":"5602_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13075-016-1052-8","volume":"18","author":"S Nakamura","year":"2016","unstructured":"Nakamura S, Suzuki K, Iijima H, Hata Y, Lim CR, Ishizawa Y, Kameda H, Amano K, Matsubara K, Matoba R, Takeuchi T (2016) Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study. Arthritis Res Ther 18:159","journal-title":"Arthritis Res Ther"},{"key":"5602_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nri.2016.124","volume":"17","author":"V Malmstr\u00f6m","year":"2017","unstructured":"Malmstr\u00f6m V, Catrina AI, Klareskog L (2017) The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol. 17:60\u201375","journal-title":"Nat Rev Immunol."},{"key":"5602_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337\u2013341","journal-title":"Science"},{"key":"5602_CR20","doi-asserted-by":"crossref","unstructured":"Lucchino B, Spinelli FR, Iannuccelli C, et al. Mucosa-environment interactions in the pathogenesis of rheumatoid arthritis. Cells. 2019;8(7)","DOI":"10.3390\/cells8070700"},{"key":"5602_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1902\/jop.2015.150455","volume":"87","author":"JM Bello-Gualtero","year":"2016","unstructured":"Bello-Gualtero JM, Lafaurie GI, Hoyos LX, Castillo DM, de-Avila J, Munevar JC, Unriza S, Londo\u00f1o J, Valle-O\u00f1ate R, Romero-S\u00e1nchez C (2016) Periodontal disease in individuals with a genetic risk of developing arthritis and early rheumatoid arthritis: a cross-sectional study. J Periodontol 87:346\u2013356","journal-title":"J Periodontol"},{"key":"5602_CR22","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1002\/art.27622","volume":"62","author":"J Leipe","year":"2010","unstructured":"Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, Schulze-Koops H, Skapenko A (2010) Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum 62:2876\u20132885","journal-title":"Arthritis Rheum"},{"key":"5602_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/art.30093","volume":"63","author":"JP van Hamburg","year":"2011","unstructured":"van Hamburg JP, Asmawidjaja PS, Davelaar N, Mus AM, Colin EM et al (2011) Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum 63:73\u201383","journal-title":"Arthritis Rheum"},{"key":"5602_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jaut.2010.10.007","volume":"36","author":"CL Hickman-Brecks","year":"2011","unstructured":"Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM (2011) Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun 36:65\u201375","journal-title":"J Autoimmun"},{"key":"5602_CR25","doi-asserted-by":"publisher","first-page":"14292","DOI":"10.1073\/pnas.1009234107","volume":"107","author":"M Mitsdoerffer","year":"2010","unstructured":"Mitsdoerffer M, Lee Y, J\u00e4ger A et al (2010) Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 107:14292\u201314297","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5602_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042189","volume":"7","author":"I Arroyo-Villa","year":"2012","unstructured":"Arroyo-Villa I, Bautista-Caro M-B, Balsa A, Aguado-Ac\u00edn P, Nu\u00f1o L, Bonilla-Hern\u00e1n MG, Puig-Kr\u00f6ger A, Mart\u00edn-Mola E, Miranda-Car\u00fas ME (2012) Frequency of Th17 CD4+ T cells in early rheumatoid arthritis: a marker of anti-CCP seropositivity. PLoS One 7:e42189","journal-title":"PLoS One"},{"key":"5602_CR27","doi-asserted-by":"crossref","unstructured":"Nie H, Zheng Y, Li R, et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat Med 2013;19::322\u2013810","DOI":"10.1038\/nm.3085"},{"key":"5602_CR28","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s10875-011-9527-5","volume":"31","author":"C \u00c1lvarez-Quiroga","year":"2011","unstructured":"\u00c1lvarez-Quiroga C, Abud-Mendoza C, Don\u00edz-Padilla L, Ju\u00e1rez-Reyes A, Monsiv\u00e1is-Urenda A, Baranda L, Gonz\u00e1lez-Amaro R (2011) CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis. J Clin Immunol 31:588\u2013595","journal-title":"J Clin Immunol"},{"key":"5602_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nri2322","volume":"8","author":"A Cerutti","year":"2008","unstructured":"Cerutti A (2008) The regulation of IgA class switching. Nat Rev Immunol 8:421\u2013434","journal-title":"Nat Rev Immunol"},{"key":"5602_CR30","doi-asserted-by":"crossref","unstructured":"Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, R\u00f6nnelid J, Rantap\u00e4\u00e4-Dahlqvist S. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis Arthritis Res Ther 2011;13: R13","DOI":"10.1186\/ar3237"},{"key":"5602_CR31","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S, de Jong BA, Berglin E et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741\u20132749","journal-title":"Arthritis Rheum"},{"key":"5602_CR32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/annrheumdis-2011-200668","volume":"71","author":"L \u00c4rlestig","year":"2012","unstructured":"\u00c4rlestig L, Mullazehi M, Kokkonen H, Rockl\u00f6v J, R\u00f6nnelid J, Dahlqvist SR (2012) Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden. Ann Rheum Dis 71:825\u2013829","journal-title":"Ann Rheum Dis"},{"key":"5602_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/art.40066","volume":"69","author":"MK Demoruelle","year":"2017","unstructured":"Demoruelle MK, Harrall KK, Ho L, Purmalek MM, Seto NL, Rothfuss HM, Weisman MH, Solomon JJ, Fischer A, Okamoto Y, Kelmenson LB, Parish MC, Feser M, Fleischer C, Anderson C, Mahler M, Norris JM, Kaplan MJ, Cherrington BD, Holers VM, Deane KD (2017) Anti-citrullinated protein antibodies are associated with neutrophil extracellular traps in the sputum in relatives of rheumatoid arthritis patients. Arthritis Rheum 69:1165\u20131175","journal-title":"Arthritis Rheum"},{"key":"5602_CR34","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","volume":"65","author":"VC Willis","year":"2013","unstructured":"Willis VC, Demoruelle MK, Derber LA, Chartier-Logan CJ, Parish MC, Pedraza IF, Weisman MH, Norris JM, Holers VM, Deane KD (2013) Sputa autoantibodies in patients with established rheumatoid arthritis and subjects at-risk for future clinically apparent disease. Arthritis Rheum 65:2545\u20132554","journal-title":"Arthritis Rheum"},{"key":"5602_CR35","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","volume":"49","author":"HL Wright","year":"2010","unstructured":"Wright HL, Moots RJ, Bucknall RC, Edwards SW (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 49:1618\u20131631","journal-title":"Rheumatology (Oxford)"},{"key":"5602_CR36","doi-asserted-by":"crossref","unstructured":"Bandyopadhyay S, Connolly SE, Jabado O, et al. Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial. Lupus Sci Med. 2017;28;4: e000206","DOI":"10.1136\/lupus-2017-000206"},{"key":"5602_CR37","first-page":"103","volume":"3","author":"FM Rodriguez","year":"2016","unstructured":"Rodriguez FM, Novak ITC (2016) Costimulatory molecules CD80 and CD86 colocalized in neutrophil extracellular traps (NETs). J Immunol Infect Dis 3:103","journal-title":"J Immunol Infect Dis"},{"key":"5602_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev.immunol.20.100101.151926","volume":"20","author":"J Sprent","year":"2002","unstructured":"Sprent J, Surh CD (2002) T cell memory. Annu Rev Immunol 20:551\u2013579","journal-title":"Annu Rev Immunol"},{"key":"5602_CR39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/ard.2009.119016","volume":"69","author":"P Emery","year":"2010","unstructured":"Emery P, Durez P, Dougados M, Legerton CW, Becker JC, Vratsanos G, Genant HK, Peterfy C, Mitra P, Overfield S, Qi K, Westhovens R (2010) Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial). Ann Rheum Dis 69:510\u2013516","journal-title":"Ann Rheum Dis"},{"key":"5602_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13063-019-3403-7","volume":"20","author":"M Al-Laith","year":"2019","unstructured":"Al-Laith M, Jasenecova M, Abraham S et al (2019) Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials. 20:429","journal-title":"Trials."},{"key":"5602_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ni.1834","volume":"11","author":"C Gur","year":"2010","unstructured":"Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O (2010) The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat Immunol 11:121\u2013128","journal-title":"Nat Immunol"},{"key":"5602_CR42","doi-asserted-by":"publisher","first-page":"491974","DOI":"10.1100\/2012\/491974","volume":"2012","author":"H Shegarfi","year":"2012","unstructured":"Shegarfi H, Naddafi F, Mirshafiey A (2012) Natural killer cells and their role in rheumatoid arthritis: friend or foe? ScientificWorldJournal. 2012:491974","journal-title":"ScientificWorldJournal."},{"key":"5602_CR43","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41598-018-37448-z","volume":"9","author":"R Yamin","year":"2019","unstructured":"Yamin R, Berhani O, Peleg H, Aamar S, Stein N, Gamliel M, Hindi I, Scheiman-Elazary A, Gur C (2019) High percentages and activity of synovial fluid NK cells present in patients with advanced stage active rheumatoid arthritis. Sci Rep 9:1351","journal-title":"Sci Rep"},{"key":"5602_CR44","doi-asserted-by":"crossref","unstructured":"Pradier A, Papaserafeim M, Li N, et al. Small-molecule immunosuppressive drugs and therapeutic immunoglobulins differentially inhibit NK cell effector functions in vitro. Front Immunol. 2019;10;10: 556","DOI":"10.3389\/fimmu.2019.00556"},{"key":"5602_CR45","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1189\/jlb.0310148","volume":"88","author":"TJ Kim","year":"2010","unstructured":"Kim TJ, Kim N, Kang HJ, Kim EO, Kim ST, Ahn HS, Bluestone JA, Lee KM (2010) FK506 causes cellular and functional defects in human natural killer cells. J Leukoc Biol 88:1089\u20131097","journal-title":"J Leukoc Biol"},{"key":"5602_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fimmu.2013.00046","volume":"4","author":"C Neudoerfl","year":"2013","unstructured":"Neudoerfl C, Mueller BJ, Blume C et al (2013) The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs. Front Immunol 4:46","journal-title":"Front Immunol"},{"key":"5602_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/art.39399","volume":"68","author":"H Yun","year":"2016","unstructured":"Yun H, Xie F, Delzell E, Levitan EB, Chen L, Lewis JD, Saag KG, Beukelman T, Winthrop KL, Baddley JW, Curtis JR (2016) Comparative risk of hospitalized infection associated with biologic agents in rheumatoid arthritis patients enrolled in Medicare. Arthritis Rheumatol. 68:56\u201366","journal-title":"Arthritis Rheumatol."},{"key":"5602_CR48","unstructured":"Yokoyama, W. M., Thompson, M. L. and Ehrhardt, R. O. Cryopreservation and thawing of cells. Curr Protoc Immunol Appendix 3, 3G"},{"key":"5602_CR49","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/art.40165","volume":"69","author":"GM Verstappen","year":"2017","unstructured":"Verstappen GM, Meiners PM, Corneth OBJ, Visser A, Arends S, Abdulahad WH, Hendriks RW, Vissink A, Kroese FGM, Bootsma H (2017) Attenuation of follicular helper T cell-dependent B cell hyperactivity by abatacept treatment in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 69:1850\u20131861","journal-title":"Arthritis Rheumatol"},{"key":"5602_CR50","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, Donlin LT, Henderson LA, Wei K, Mizoguchi F, Teslovich NC, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Lee YC, Todd DJ, Bykerk VP, Goodman SM, Pernis AB, Ivashkiv LB, Karlson EW, Nigrovic PA, Filer A, Buckley CD, Lederer JA, Raychaudhuri S, Brenner MB (2017) Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 542:110\u2013114","journal-title":"Nature."},{"key":"5602_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","volume":"15","author":"Z Chen","year":"2019","unstructured":"Chen Z, Bozec A, Ramming A, Schett G (2019) Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol 15:9\u201317","journal-title":"Nat Rev Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05602-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T19:01:22Z","timestamp":1698001282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05602-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5602"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05602-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-16418\/v1","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"16 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of our institution (the Ethics Committee of Keio University School of Medicine; 2009173).Written informed consent was obtained from all the patients in accordance with the Declaration of Helsinki protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"J.I has declared no conflicts of interest. Y.K. has received grants or speaking fees from AbbVie, Astellas, Ayumi, Bristol-Myers, Chugai, Eisai, Eli Lilly, Hisamitsu, Jansen, Kissei, Pfizer, Sanofi, Takeda, Mitsubishi Tanabe, and UCB. J.K. has received grants or speaking fees from Astellas, Bristol-Myers, Chugai, Eisai, and Janssen. T.T. has received research grants or speaking fees from AbbVie, Asahi Kasei, Astellas, Astra Zeneca, Bristol-Myers, Chugai, Daiichi Sankyo, Eli Lilly, Janssen, Mitsubishi Tanabe, Novartis, Nippon Kayaku, Taiho, Takeda, Teijin, and Pfizer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}